Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases

International Immunology

Volumn 16, Issue 2, 2004, Pages 303-314

  Fujimoto, Minoru ^a   Tsutsui, Hiroko ^b,e   Xinshou, Ouyang ^a   Tokumoto, Masanori ^c   Watanabe, Dai ^a   Shima, Yoshihito ^a   Yoshimoto, Tomohiro ^b,e   Hirakata, Hideki ^c   Kawase, Ichiro ^a   Nakanishi, Kenji ^b,e   Kishimoto, Tadamitsu ^d   Naka, Tetsuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Autoantibody; Janus kinase; STAT induced STAT inhibitor; Suppressor of cytokine signaling; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; DNA ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEPOSITION; IN VIVO STUDY; LYMPHOID CELL; MALE; MOUSE; MUTANT; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC DISEASE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD4; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CARRIER PROTEINS; DNA-BINDING PROTEINS; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-2; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TH1 CELLS; TRANS-ACTIVATORS;

EID: 10744227089     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh030     Document Type: Article

References (43)

1. Wakeland, E. K., Liu, K., Graham, R. R. and Behrens, T. W. 2001. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397.
2. Marrack, P., Kappler, J. and Kotzin, B. L. 2001. Autoimmune disease: why and where it occurs. Nat. Med. 7:899.
3. Erb, K. J., Ruger, B., von Brevern, M., Ryffel, B., Schimpl, A. and Rivett, K. 1997. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J. Exp. Med. 185:329.
4. Seery, J. P., Carroll, J. M., Cattell, V. and Watt, F. M. 1997. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J. Exp. Med. 186:1451.
5. h2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis. Rheum. 42:1644.
6. Ioannou, Y. and Isenberg, D. A. 2000. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis. Rheum. 43:1431.
7. O'Shea, J. J., Ma, A. and Lipsky, P. 2002. Cytokines and autoimmunity. Nat. Rev. Immunol. 2:37.
8. Naka, T., Fujimoto, M. and Kishimoto, T. 1999. Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. Trends. Biochem. Sci. 24:394.
9. Yasukawa, H., Sasaki, A. and Yoshimura, A. 2000. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 18:143.
10. Krebs, D. L. and Hilton, D. J. 2001. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378.
11. Marine, J. C., Topham, D. J., McKay, C., Wang, D., Parganas, E., Stravopodis, D., Yoshimura, A. and Ihle, J. N. 1999. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98:609.
12. Naka, T., Matsumoto, T., Narazaki, M., Fujimoto, M., Morita, Y., Ohsawa, Y., Saito, H., Nagasawa, T., Uchiyama, Y. and Kishimoto, T. 1998. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl Acad. Sci. USA 95:15577.
13. Starr, R., Metcalf, D., Elefanty, A. G., Brysha, M., Willson, T. A., Nicola, N. A., Hilton, D. J. and Alexander, W. S. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling. Proc. Natl Acad. Sci. USA 95:14395.
14. Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S., Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M., Kay, T. W., Nicola, N. A., Hertzog, P. J., Metcalf, D. and Hilton, D. J. 1999. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98:597.
15. Naka, T., Tsutsui, H., Fujimoto, M., Kawazoe, Y., Kohzaki, H., Morita, Y., Nakagawa, R., Narazaki, M., Adachi, K., Yoshimoto, T., Nakanishi, K. and Kishimoto, T. 2001. SOCS-1/SSI-1 -deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity 14:535.
16. Cornish, A. L., Davey, G. M., Metcalf, D., Purton, J. F., Corbin, J. E., Greenhalgh, C. J., Darwiche, R., Wu, L., Nicola, N. A., Godfrey, D. I., Heath, W. R., Hilton, D. J., Alexander, W. S. and Starr, R. 2003. Suppressor of cytokine signaling-1 has IFN-gamma-independent actions in T cell homeostasis. J. Immunol. 170:878.
17. Koike, M., Kikuchi, Y., Tominaga, A., Takaki, S., Akagi, K., Miyazaki, J., Yamamura, K. and Takatsu, K. 1995. Defective IL-5-receptor-mediated signaling in B cells of X-linked immunodeficient mice. Int. Immunol. 7:21.
18. Fujimoto, M., Naka, T., Nakagawa, R., Kawazoe, Y., Morita, Y., Tateishi, A., Okumura, K., Narazaki, M. and Kishimoto, T. 2000. Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1/suppressors of cytokine signaling-1 transgenic mice. J. Immunol. 165:1799.
19. Kawazoe, Y., Naka, T., Fujimoto, M., Kohzaki, H., Morita, Y., Narazaki, M., Okumura, K., Saitoh, H., Nakagawa, R., Uchiyama, Y., Akira, S. and Kishimoto, T. 2001. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J. Exp. Med. 193:263.
20. Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T. and Koyasu, S. 200Z PI3K-mediated negative feedback regulation of IL-12 production in DC. Nat. Immunol. 3:875.
21. Nakanishi, K., Matsui, K., Kashiwamura, S., Nishioka, Y., Nomura, J., Nishimura, Y., Sakaguchi, N., Yonehara, S., Higashino, K. and Shinka, S. 1996. IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation. Int. Immunol. 8:791.
22. h polarization in vivo. Int. Immunol. 14:1343.
23. Nakagawa, R., Naka, T., Tsutsui, H., Fujimoto, M., Kimura, A., Abe, T., Seki, E., Sato, S., Takeuchi, O., Takeda, K., Akira, S., Yamanishi, K., Kawase, I., Nakanishi, K. and Kishimoto, T. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17:677.
24. Lindeman, G. J., Wittlin, S., Lada, H., Naylor, M. J., Santamaria, M., Zhang, J. G., Starr, R., Hilton, D. J., Alexander, W. S., Ormandy, C. J. and Visvader, J. 2001. SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes Dev. 15:1631.
25. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455.
26. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.
27. Maloy, K. J. and Powrie, F. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816.
28. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311.
29. + suppressor T cells in vivo. Nat. Immunol. 3:33.
30. Seo, S. J., Fields, M. L., Buckler, J. L., Reed, A. J., Mandik-Nayak, L., Nish, S. A., Noelle, R. J., Turka, L. A., Finkelman, F. D., Caton, A. J. and Erikson, J. 2002. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16:535.
31. Bystry, R. S., Aluvihare, V., Welch, K. A., Kallikourdis, M. and Betz, A. G. 2001. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol, 2:1126.
32. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969.
33. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
34. Sporri, B., Kovanen, P. E., Sasaki, A., Yoshimura, A. and Leonard, W. J. 2001. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Blood 97:221.
35. Peeva, E., Michael, D., Cleary, J., Rice, J., Chen, X. and Diamond, B. 2003. Prolactin modulates the naive B cell repertoire. J. Clin. Invest. 111:275.
36. Eyles, J. L., Metcalf, D., Grusby, M. J., Hilton, D. J. and Starr, R. 2002. Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling. J. Biol. Chem. 277:43735.
37. Cornish, A. L., Chong, M. M., Davey, G. M., Darwiche, R., Nicola, N. A., Hilton, D. J., Kay, T. W., Starr, R. and Alexander, W. S. 2003. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells. J. Biol. Chem. 278:22755.
38. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303.
39. + regulatory T cell function. J. Exp. Med. 196:851.
40. + T cell numbers. J. Immunol. 169:4850.
41. Wang, Y., Nose, M., Kamoto, T., Nishimura, M. and Hiai, H. 1997. Host modifier genes affect mouse autoimmunity induced by the Ipr gene. Am. J. Pathol. 151:1791.
42. Nagai, H., Kim, Y. S., Lee, K. T., Chu, M. Y., Konishi, N., Fujimoto, J., Baba, M., Matsubara, K. and Emi, M. 2001. Inactivation of SSI-1, a JAK/STAT inhibitor, in human hepatocellular carcinomas, as revealed by two-dimensional electrophoresis. J. Hepatol. 34:416.
43. Yoshikawa, H., Matsubara, K., Qian, G. S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C. and Herman, J. G. 2001. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 28:29.